The EMA perspective: Case studies from the PDCO formulations group (chemicals & biologicals)

The EMA perspective: Case studies from the PDCO formulations group (chemicals & biologicals)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2012-10, Vol.435 (2), p.131-132
Hauptverfasser: LeBarbier, Caroline, Esteve, Isabel
Format: Artikel
Sprache:eng
Schlagworte:
Biological Products
Chemistry, Pharmaceutical
Child
European Union
Humans
Legislation, Drug
Pharmaceutical Preparations
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 132
container_issue 2
container_start_page 131
container_title International journal of pharmaceutics
container_volume 435
creator LeBarbier, Caroline
Esteve, Isabel
description
doi_str_mv 10.1016/j.ijpharm.2012.05.052
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1033457505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517312005522</els_id><sourcerecordid>1033457505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-871195f4760b9f804704c60f5e20b47a151ccf2cc9da25b98d93853ac77adb423</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMoun78BCUn0UPXfDRN60Vk_YSV9aA3IaTp1M3SbmrSCv57s-7qVRgYBp7MO3kQOqZkTAnNLhZju-jm2rdjRigbExGLbaERzSVPeCqzbTQiXOaJoJLvof0QFoSQjFG-i_YYy3OeFekIvb3MAd8-XeMOfOjA9PYTLvFEB8ChHyoLAdfetbiP2PPNZIZr59uh0b11y4DfvRs6fGbm0Fqjm4BPcWld495_pvNDtFPHDkebfoBe725fJg_JdHb_OLmeJoZnok9ySWkh6ngzKYs6J6kkqclILYCRMpWaCmpMzYwpKs1EWeRVwXPBtZFSV2XK-AE6W-_tvPsYIPSqtcFA0-gluCEoSjhPhRRERFSsUeNdCB5q1Xnbav8VIbUSqxZqI1atxCoiYq0iTjYRQ9lC9ffq12QErtYAxI9-WvAqGAtLA5X1UauqnP0n4hszrYsc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1033457505</pqid></control><display><type>article</type><title>The EMA perspective: Case studies from the PDCO formulations group (chemicals &amp; biologicals)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>LeBarbier, Caroline ; Esteve, Isabel</creator><creatorcontrib>LeBarbier, Caroline ; Esteve, Isabel</creatorcontrib><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2012.05.052</identifier><identifier>PMID: 22883694</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Biological Products ; Chemistry, Pharmaceutical ; Child ; European Union ; Humans ; Legislation, Drug ; Pharmaceutical Preparations</subject><ispartof>International journal of pharmaceutics, 2012-10, Vol.435 (2), p.131-132</ispartof><rights>2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-871195f4760b9f804704c60f5e20b47a151ccf2cc9da25b98d93853ac77adb423</citedby><cites>FETCH-LOGICAL-c365t-871195f4760b9f804704c60f5e20b47a151ccf2cc9da25b98d93853ac77adb423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2012.05.052$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22883694$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LeBarbier, Caroline</creatorcontrib><creatorcontrib>Esteve, Isabel</creatorcontrib><title>The EMA perspective: Case studies from the PDCO formulations group (chemicals &amp; biologicals)</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><subject>Biological Products</subject><subject>Chemistry, Pharmaceutical</subject><subject>Child</subject><subject>European Union</subject><subject>Humans</subject><subject>Legislation, Drug</subject><subject>Pharmaceutical Preparations</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LxDAQhoMoun78BCUn0UPXfDRN60Vk_YSV9aA3IaTp1M3SbmrSCv57s-7qVRgYBp7MO3kQOqZkTAnNLhZju-jm2rdjRigbExGLbaERzSVPeCqzbTQiXOaJoJLvof0QFoSQjFG-i_YYy3OeFekIvb3MAd8-XeMOfOjA9PYTLvFEB8ChHyoLAdfetbiP2PPNZIZr59uh0b11y4DfvRs6fGbm0Fqjm4BPcWld495_pvNDtFPHDkebfoBe725fJg_JdHb_OLmeJoZnok9ySWkh6ngzKYs6J6kkqclILYCRMpWaCmpMzYwpKs1EWeRVwXPBtZFSV2XK-AE6W-_tvPsYIPSqtcFA0-gluCEoSjhPhRRERFSsUeNdCB5q1Xnbav8VIbUSqxZqI1atxCoiYq0iTjYRQ9lC9ffq12QErtYAxI9-WvAqGAtLA5X1UauqnP0n4hszrYsc</recordid><startdate>20121005</startdate><enddate>20121005</enddate><creator>LeBarbier, Caroline</creator><creator>Esteve, Isabel</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121005</creationdate><title>The EMA perspective: Case studies from the PDCO formulations group (chemicals &amp; biologicals)</title><author>LeBarbier, Caroline ; Esteve, Isabel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-871195f4760b9f804704c60f5e20b47a151ccf2cc9da25b98d93853ac77adb423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biological Products</topic><topic>Chemistry, Pharmaceutical</topic><topic>Child</topic><topic>European Union</topic><topic>Humans</topic><topic>Legislation, Drug</topic><topic>Pharmaceutical Preparations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LeBarbier, Caroline</creatorcontrib><creatorcontrib>Esteve, Isabel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LeBarbier, Caroline</au><au>Esteve, Isabel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The EMA perspective: Case studies from the PDCO formulations group (chemicals &amp; biologicals)</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2012-10-05</date><risdate>2012</risdate><volume>435</volume><issue>2</issue><spage>131</spage><epage>132</epage><pages>131-132</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>22883694</pmid><doi>10.1016/j.ijpharm.2012.05.052</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2012-10, Vol.435 (2), p.131-132
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_1033457505
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Biological Products
Chemistry, Pharmaceutical
Child
European Union
Humans
Legislation, Drug
Pharmaceutical Preparations
title The EMA perspective: Case studies from the PDCO formulations group (chemicals & biologicals)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A25%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20EMA%20perspective:%20Case%20studies%20from%20the%20PDCO%20formulations%20group%20(chemicals%20&%20biologicals)&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=LeBarbier,%20Caroline&rft.date=2012-10-05&rft.volume=435&rft.issue=2&rft.spage=131&rft.epage=132&rft.pages=131-132&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2012.05.052&rft_dat=%3Cproquest_cross%3E1033457505%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1033457505&rft_id=info:pmid/22883694&rft_els_id=S0378517312005522&rfr_iscdi=true